Biotech

All Articles

Lilly posts a lot more good data on its every week insulin prospect

.On the heels of an FDA rejection for its own main rival Novo Nordisk, Eli Lilly is making headway i...

IN 8bio standstills stage 2 test, lays off fifty percent of staff

.Just a handful of months after dosing the very first person in a phase 2 test for newly identified ...

Lilly, Haya ink $1B biobuck obesity deal to search dark genome

.Eli Lilly's hunt for being overweight targets has actually led it to the dark genome. The Big Pharm...

ArsenalBio elevates $325M, pivots out of previous lead property

.Arsenal Biosciences is actually moving on up. The cell therapy company has actually added on $325 t...

Lilly- backed fat loss biotech data IPO

.After increasing $170 thousand back in February, metabolic disease-focused BioAge Labs has filed to...

Aelis' marijuana make use of drug fails phase 2b, driving Indivior to review $100M option

.Aelis Farma's chances of securing a fast, good choice on a $100 million choice remittance have actu...

ProKidney standstills period 3 trial not needed for tissue treatment approval

.ProKidney has ceased some of a set of period 3 trials for its own tissue treatment for renal ailmen...

Vaxcyte climbs on 'remarkable' 31-valent PCV win against Pfizer

.Vaxcyte introduced what analysts named "stunning" period 1/2 records for its 31-valent pneumococcal...

Recursion's brain illness test shows insufficient evidence of effectiveness

.Recursion has discovered through an early examination of its tech-enabled approach to medicine reve...

Acepodia, Pfizer click together for chemistry-based cell therapy

.Contact it an instance of great chemical make up: Acepodia, a biotech based upon Nobel Champion sci...